Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Leukemia & Lymphoma
|
October 24, 2000
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacy
G H Jackson, B Angus, P J Carey, et al.
Leukemia
|
August 13, 2011
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
K D Boyd, F M Ross, L Chiecchio, et al.
Blood Cancer Journal
|
April 1, 2017
Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control
C Pawlyn, M D Bright, A F Buros, et al.
Journal of Medical Genetics
|
October 26, 2007
Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma
L J Worrillow, A G Smith, K Scott, et al.
Leukemia
|
December 17, 2015
Genetic factors influencing the risk of multiple myeloma bone disease
D C Johnson, N Weinhold, J Mitchell, et al.
Blood Cancer Journal
|
December 10, 2016
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial
J R Jones, D A Cairns, W M Gregory, et al.
Leukemia
|
January 22, 2010
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia
J M Allan, N J Sunter, J R Bailey, et al.
Leukemia
|
June 7, 2017
Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients
V Shah, A L Sherborne, B A Walker, et al.
Leukemia
|
November 4, 2014
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk
G P Sava, H E Speedy, M C Di Bernardo, et al.
Blood Cancer Journal
|
June 17, 2017
Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach
M Went, A Sud, P J Law, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Leukemia & Lymphoma
|
October 24, 2000
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacy
G H Jackson, B Angus, P J Carey, et al.
Leukemia
|
August 13, 2011
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
K D Boyd, F M Ross, L Chiecchio, et al.
Blood Cancer Journal
|
April 1, 2017
Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control
C Pawlyn, M D Bright, A F Buros, et al.
Journal of Medical Genetics
|
October 26, 2007
Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma
L J Worrillow, A G Smith, K Scott, et al.
Leukemia
|
December 17, 2015
Genetic factors influencing the risk of multiple myeloma bone disease
D C Johnson, N Weinhold, J Mitchell, et al.
Blood Cancer Journal
|
December 10, 2016
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial
J R Jones, D A Cairns, W M Gregory, et al.
Leukemia
|
January 22, 2010
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia
J M Allan, N J Sunter, J R Bailey, et al.
Leukemia
|
June 7, 2017
Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients
V Shah, A L Sherborne, B A Walker, et al.
Leukemia
|
November 4, 2014
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk
G P Sava, H E Speedy, M C Di Bernardo, et al.
Blood Cancer Journal
|
June 17, 2017
Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach
M Went, A Sud, P J Law, et al.
Page
of 7